Blood Cancer
Showing 49–64 of 71 results
-
RYZNEUTA (efbemalenograstim alfa-vuxw)
Read more -
SCEMBLIX (asciminib) tablets
Read more -
SOHONOS (palovarotene) capsules
Read more -
SOTYKTU (deucravacitinib) tablets
Read more -
SPEVIGO (spesolimab-sbzo) injection
Read more -
TAFINLAR (dabrafenib) capsules, for oral use. Initial U.S. Approval: 2013
Read more -
TALVEY (talquetamab-tgvs)
Read more -
Tasigna (nilotinib) Capsules Initial U.S. Approval: 2007
Read more -
TAVALISSE (fostamatinib disodium hexahydrate) tablets, for oral use Initial U.S. Approval: 2018
Read more -
TECVAYLI (teclistamab-cqyv) injection
Read more -
TIBSOVO (ivosidenib tablets), for oral use. Initial U.S. Approval: 2018
Read more -
VANFLYTA (quizartinib)
Read more -
VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016
Read more -
VEYVONDI 650 IU powder and solvent for solution for injection
Read more -
VONVENDI (recombinant) lyophilized powder for solution
Read more -
VYXEOS (daunorubicin and cytarabine) liposome for injection
Read more
